SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 69.35 |
| Enterprise Value ($M) | 78.46 |
| Book Value ($M) | -12.67 |
| Book Value / Share | -0.31 |
| Price / Book | -5.47 |
| NCAV ($M) | -18.25 |
| NCAV / Share | -0.45 |
| Price / NCAV | -3.80 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.49 |
| Current Ratio | 2.49 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 31.53 |
| Assets | 37.10 |
| Liabilities | 49.77 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -8.75 |
| Net Income | -11.12 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -16.44 |
| Cash from Investing | -12.01 |
| Cash from Financing | 26.79 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Ever Regal Group Ltd | 15.01 | -40.76 | |
| 13G/A | Decheng Capital Management III (Cayman), LLC | 12.30 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,236 | 15,348 | 8.05 | |
| 1,199 | 12,552 | 9.55 | |
| 2,380 | 22,326 | 10.66 | |
| 547 | 18,566 | 2.95 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| BON – Bon Natural Life Limited | BTAI – BioXcel Therapeutics, Inc. |
| BULL – Webull Corporation | CALC – CalciMedica, Inc. |
| CAPR – Capricor Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io